Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of RO0506997 in relapsing multiple sclerosis
2004-004519-43Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing RO0506997 with Placebo (2 arms). Primary endpoints: Cumulative number of MRI enhancing lesions, Cumulative number of active MRI lesions and 3 more. Started Feb 2005; status: completed.
02
Drugs
RO0506997
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-004519-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004519-43.